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Abstract We demonstrated for the first time the presence of
sphingomyelinase (SMase) in Helicobacter pylori. Activation of
SMase has been implicated as the cause of elevation of cellular
ceramide levels and consequently of apoptosis. The data indicate
that there are two classes of SMase, defined by their optimal pHs
and cellular locations, existing in H. pylori. One is an Mg2+-
dependent membrane-bound enzyme with an optimal activity at
pH 7, and the other is an Mg2+-independent cytosolic enzyme
with an optimal activity at pH 5. Bisalumin, a bismuth salt, was
found to inhibit the activities of both forms of SMase regardless
of the presence of Mg2+. By Western blot analysis, the
membrane-bound SMases of H. pylori and Bacillus cereus were
shown to be antigenically related and to have a similar denatured
molecular mass of 28 kDa.
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1. Introduction
Helicobacter pylori is a bacterial pathogen which is strongly
associated with human gastritis, peptic ulcer and gastric can-
cer [1^7]. Infection of H. pylori begins with gastric mucus
colonization, followed by attachment of the bacteria to the
speci¢c portions of epithelial cells [8]. Human gastric epithe-
lium protects itself against various noxious factors attacks by
the lipid hydrophobic barrier [9^12]. A recent report on the
ultrastructure analysis has documented that H. pylori infec-
tion damages the phospholipid-rich epithelial layer of gastric
mucosa [13], and the gastric mucosal hydrophobicity of H.
pylori-infected patients can return to normal values after erad-
ication of H. pylori [14]. Among the enzymes of H. pylori,
phospholipases have reactive targets on gastric epithelial cell
membrane as well as on the lipid hydrophobic layer on the
surface of the mucus gel. In previous studies, two types of
phospholipases, phospholipases A and C, have been identi¢ed
in H. pylori. They were regarded as the pathogenic factors
owing to their actions on epithelial cell membrane [15,16].
In the present study, we attempt to determine whether or
not sphingomyelinase (SMase), an important phospholipase,
exists in the common pathogenic bacteria, H. pylori. SMase
catalyzes the hydrolytic reaction of sphingomyelin (SM) to
form the lipid moiety ceramide and water soluble choline-
phosphate derivative. These sphingolipids are regarded as ac-
tive participants in the regulation of cell growth, di¡erentia-
tion, and apoptosis [17]. Therefore, should SMase exist in H.
pylori, it may play a potential role in pathogenesis of gastric
ulcer diseases.
2. Materials and methods
2.1. Materials
N-g-Trinitrophenylaminolauryl-sphingomyelin (TNPAL-SM), crude
sphingomyelin (SM) (bovine brain extract, type viii), phenylmethyl-
sulfonyl £uoride (PMSF), bisalumin, bovine serum albumin, ethylene-
diamine tetraacetic acid (EDTA, trisodium salt) and all other organic
compounds were purchased from Sigma (St. Louis, MO). Chocolate-
agar plates were purchased from Difco (Detroit, MI).
2.2. Bacterial isolates and cultivation
The Helicobacter pylori strains from ulcer patients were kindly giv-
en by Dr. N. Lee of Chang Gung memorial hospital, Taiwan. Twelve
strains were screened quantitatively for SMase activity. The bacteria
were cultured on chocolate agar plates at 37‡C in a microaerophilic
atmosphere of 10% CO2 in air and 99% humidity for three days. H.
pylori strains were identi¢ed by Gram stain morphology, urease test,
and histology.
2.3. Preparation of H. pylori proteins
The H. pylori cells grown on chocolate agar plates were washed out
with phosphate bu¡er saline (PBS, pH 7.2). The harvested bacterial
cells were washed twice in PBS and then resuspended in 0.2 M gly-
cine-HCl bu¡er (pH 2.2). The suspension was stirred at 25‡C for 15
min and centrifuged at 4‡C for 15 min. The supernatant was neutral-
ized with NaOH and dialyzed against distilled water at 4‡C overnight,
and used as a membrane fraction for SMase assay. The intact H.
pylori pellet was then resuspended in 50 mM PBS containing 1 mM
PMSF and 2 mM EDTA and was disrupted by sonication (Heat-
System Model XL 200, NY) in an ice bath at 35% pulse with 30-s
intervals for 5 min. The solution was centrifuged at 15 000Ug for
10 min at 4‡C. The supernatant was used as the cytosolic portion
for SMase assay. Protein concentration was determined by the Brad-
ford dye binding assay using bovine serum albumin as a standard.
2.4. SMase assay
The activity of both neutral SMase (N-SMase) and acidic SMase
(A-SMase) were determined by the ability of the enzyme to hydrolyze
the substrate analog, TNPAL-SM, as described previously [20,21].
For determining N-SMase activity, enzyme preparation (100 Wl, 0.3^
0.6 mg of protein) diluted to 200 Wl with 50 mM PBS, pH 7.4, was
mixed with 20 nmol of TNPAL-SM dissolved in 0.05% Triton X-100
in 50 Wl of 100 mM PBS, pH 7.4, containing 5 mM magnesium
chloride. The reaction processed for 2 h at 37‡C and was then termi-
nated by the addition of 0.75 ml of isopropanol/heptane/5 M H2SO4
(40:10:1, v/v) followed by 0.4 ml of H2O and 0.45 ml of heptane.
After phase separation, a portion of the upper phase was removed
and the reaction product, trinitrophenylamino (TNPAL) residue was
measured at 330 nm spectrophotometrically, and 1 nmol gave 0.023
absorbance units. A-SMase activity was determined using TNPAL-
SM resuspended in 50 Wl of 100 mM sodium acetate, pH 5.0. One unit
of activity was de¢ned as the amount of SMase which catalyzed the
hydrolysis of 1 nmol of TNPAL-SM per hour at 37‡C. Speci¢c activ-
ity was given as units of enzyme activity per milligram of protein. The
e¡ects of di¡erent pH, magnesium ion, and bisalumin concentrations
on the SMase activity were examined.
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2.5. Immunoblotting
Puri¢ed Bacillus cereus SMase and H. pylori lysate were subjected
to SDS-PAGE (10% polyacrylamide) and were transferred by Western
blot to nitrocellulose membrane (Millipore, Bedford, MA) in 10 mM
phosphate bu¡er, pH 7.2, and immunostaining was performed as
described previously [18,22]. Antiserum to the puri¢ed SMase of B.
cereus (Sigma Co.) was raised in female New Zealand White rabbits as
previously described [19]. Two milliliters of enzyme solution were
mixed with an equal volume of Freund complete adjuvant and in-
jected subcutaneously into eight sites on the back and hind legs of
each rabbit. Booster doses were given in a similar manner in Freund
incomplete adjuvant 14 and 28 days after initial immunization. On
day 42, the rabbits were bled, and the serum was collected and stored
at 320‡C in 100-Wl samples. Preimmune serum was taken and used as
a negative control serum. For the immunoblotting experiments, the
rabbit antisera were diluted 1:200.
3. Results
Twelve strains of H. pylori isolated from humans were
screened quantitatively for SMase activity. SMase activity
was measured as the ability to hydrolyze an SM analog
TNPAL-SM. H. pylori cells were harvested from chocolate
agar plates and lysing them by sonication. Lysates were
then assayed for SMase activity. We determined the speci¢c
activities of SMase which varied from 2.12 to 15.62 nmol of
TNPAL-SM hydrolyzed per h/mg of protein from 12 strains
(Table 1). Data show that strain K8 has an SMase-speci¢c
activity of 15.6 nmol/h/mg protein, which is much higher than
that of others. Interestingly, the strain K8 was from a patient
with a severe duodenal ulcer as well as gastric ulcer, and the
other isolates were from patients with either duodenal ulcer,
gastric ulcer, or dyspepsia. Strain K8 was used exclusively in
the characterization of SMase because it grew well under lab-
oratory conditions and showed no signi¢cant change in
SMase-speci¢c activity on repeated subculture.
As part of the biochemical characterization of SMase, we
initially examined the e¡ect of pH on the in vitro activity of
the enzyme. SMase activity of H. pylori lysate was measured
at 37‡C with bu¡ers ranging from pH 2 to 10, and two opti-
mal pH values for activity were determined at pH 5 and pH 7,
respectively (Fig. 1). This result supports the existence of dif-
ferent forms of SMase in H. pylori ; one is neutral isoform and
the other one is acidic isoform of SMase. In H. pylori, N-
SMase contributes approximately 85% of the total activity,
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Table 1
SMase activities from twelve clinical H. pylori isolates
Clinical
strains
Endoscope
diagnosis
SMase activitya
(nmol/h/mg protein)
K7 GUb 3.50
K8 GU, DUb 15.62
K34 DU 2.83
K85 Noneb 2.93
K86 DU 3.13
K89 DU 2.12
K93 GU 3.10
34 Dyspepsia 2.85
36 DU 2.45
37 GU 2.55
41 DU 2.88
46 Dyspepsia 2.93
aThe whole cell lysate bu¡ered in pH 7 was used for SMase assay.
bGU: gastric ulcer; DU: duodenal ulcer; None: no symptom.
Fig. 1. E¡ect of pH on the SMase activity in H. pylori lysate. Activ-
ity measurements of 100 Wl whole cell lysate (400 Wg protein) were
carried out after 20 min incubation at 37‡C with bu¡ers ranging
from pH 2 to 10 (pH 2^5.6, acetate; pH 5.8^8.5, Na2B4O7/HCl;
pH 9^10, Na2B4O7/NaOH). Symbol E indicates lysate mixing with
20 mM EDTA; symbol a indicates lysate not mixing with EDTA.
The results are the means þ S.E.M. of four separate experiments,
each performed in at least triplicate.
Fig. 2. E¡ect of the concentration of Mg2 on the SMase activity.
H. pylori lysate (100 Wl, 400 Wg protein) was mixed with 100 Wl of
5 mM EDTA in 0.05 M PBS (pH 7.2) and in 0.05 M acetate bu¡er
(pH 5), and was kept at 5‡C for 2 h. Then 0.1 ml of magnesium
chloride solution at various concentrations was added to each mix-
ture. After being allowed to stand for 1 h at 5‡C, the sample was
subjected to SMase assay.
Y. Lin et al./FEBS Letters 423 (1998) 249^253250
and A-SMase contributes the rest. We next examined the ef-
fect of Mg2 concentrations on SMase activities. As shown in
Fig. 2, incubation of H. pylori lysate with concentrations of
magnesium chloride ranging from 0 to 2.5 mM resulted in a
linear activation of the SMase. In contrast to N-SMase, mag-
nesium chloride at concentrations ranging from 0 to 2.5 mM
was completely ine¡ective on the activity of A-SMase (Fig. 2).
By adding EDTA to the H. pylori lysate, the activity of N-
SMase was completely inhibited, and the activity of A-SMase
was not a¡ected (Fig. 1). Nevertheless, adding the excess
amount of Mg2 ion could restore the EDTA-inhibited N-
SMase activity (data not shown). These results indicate that
N-SMase is Mg2-dependent, but A-SMase is not. Data also
showed that adding bisalumin, a bismuth-containing com-
pound used in the treatment of gastric disorders, at a concen-
tration of 1 mM, could inhibit the activities of both N-SMase
and A-SMase in the presence of Mg2 (Fig. 2).
We next investigated cellular locations of SMases to deter-
mine whether it was in a membrane fraction or in H. pylori
cytosol. To this end, we used the glycine-extractable proteins
from H. pylori as a membrane fraction for SMase assay. As
shown in Fig. 3, the majority of N-SMase activity was found
in a membrane fraction with an insigni¢cant amount of A-
SMase activity, and incubation of the membrane fraction at
37‡C with 1 mM bisalumin resulted in a 100% inhibition of
N-SMase activity regardless the presence of Mg2. The intact
cells without any treatment also appeared to have an N-
SMase activity and to be free of A-SMase activity (Fig. 4).
This result implicates that N-SMase may be located on the
outer membrane of H. pylori. On the other hand, the N-
SMase activity was found to be nearly absent from H. pylori
cytosolic fraction which was prepared from cells previously
extracted by 0.2 M glycine-HCl bu¡er, and A-SMase was
found to be a major form in H. pylori cytosol (Fig. 5).
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Fig. 3. E¡ect of pH on the SMase activity in H. pylori membrane
portion. The experimental conditions were described in Fig. 1. Sym-
bol E indicates lysate mixing with 1 mM bisalumin; symbol a indi-
cates lysate not mixing with bisalumin. The results are the means
þ S.E.M. of four separate experiments, each run performed in at
least triplicate.
Fig. 4. E¡ect of pH on the SMase activity of intact H. pylori cells.
The experimental conditions were described in Fig. 1, and 106 cells
were used for SMase assay. Symbol E indicates lysate mixing with
1 mM bisalumin; symbol a indicates lysate not mixing with bisalu-
min. The results are the means þ S.E.M. of four separate experi-
ments, each run performed in at least triplicate.
Fig. 5. E¡ect of pH on the SMase activity in H. pylori cytosol. The
experimental conditions were described in Fig. 1. Symbol E indi-
cates lysate mixing with 1 mM bisalumin; symbol a indicates lysate
not mixing with bisalumin. The results are the means þ S.E.M. of
four separate experiments, each run performed in at least triplicate.
Y. Lin et al./FEBS Letters 423 (1998) 249^253 251
By Western blot analysis, antiserum raised against the pu-
ri¢ed B. cereus N-SMase recognized the 28-kDa protein from
H. pylori membrane and no other protein constituents (Fig.
6). This result suggests that N-SMase produced by H. pylori
and B. cereus are antigenically related. The antiserum did not
recognize any protein from H. pylori cytosol (data not
shown). There are two implications to this result. First, H.
pylori A-SMase is not antigenically related to B. cereus N-
SMase. Second, the amount of A-SMase is insu⁄cient to be
detected. The data of Fig. 6 also show that the denatured N-
SMases from both bacteria have a similar molecular mass of
approximately 28 kDa.
4. Discussion
In the present study, SMase activity of H. pylori is observed
which is generally expressed by the clinical isolates. We iden-
ti¢ed two isoforms of SMase existing in H. pylori. One is a
neutral Mg2-dependent membrane-bound enzyme with an
optimal activity at pH 7, and the other is an acidic Mg2-
independent cytosolic enzyme with an optimal activity at pH
5. Among the twelve H. pylori isolates, a strain K8 isolated
from a patient with duodenal and gastric ulcers was found to
have a much higher total activity of SMase than that of
others. Because of the insu⁄cient number of H. pylori isolates
tested at this stage, it was impossible to draw a conclusion on
SMase activity appearing to correlate with pathogenesis.
However, in epidemiology it is interesting to know the corre-
lation between them.
Ikezawa et al. showed that SMase of Bacillus cereus was a
neutral enzyme with a molecular mass of 24 kDa [23]. In the
present study, results show that the properties of H. pylori
membrane-bound N-SMase resemble those in B. cereus with
respect to Mg2 dependence and optimal pH value. In addi-
tion to the Mg2-dependent form of membrane-bound N-
SMase, we also found an Mg2-independent A-SMase form
in H. pylori cytosol. In mammalian cells, although the A-
SMase has been primarily found to reside in the lysosomes,
it has also been detected as a soluble form in cytosol [24].
Both N-SMase and A-SMase have been suggested to play a
role in induction of cellular apoptosis [25]. In this study we
demonstrated that both H. pylori N-SMase and A-SMase
were inactivated at pH 2 (Fig. 2). This evidence suggests
that H. pylori SMases are inactivated in the stomach. How-
ever, H. pylori membrane-bound urease gives this bacterium
the ability to survive in acid, by production of ammonia from
urea substrate, to penetrate the mucus surface and colonize a
more alkaline environment. Therefore, in the local alkaline
environment created by H. pylori, activities of SMases may
be restored in the stomach and subsequently involved in the
induction of apoptosis. Study results also showed that bis-
muth salt, an agent that was found to inhibit phospholipases
A and C [26], inhibited the activity of H. pylori SMase.
Although the inhibitory mechanism of bismuth salt is not
clear and remains to be studied, a possible model for inacti-
vation due to an ionic interaction between bismuth and en-
zyme has been proposed [27].
In Western blot analysis, unfortunately, the amount of the
puri¢ed H. pylori SMase was not enough to perform the im-
munization to raise the antiserum. Instead, a puri¢ed B. ce-
reus N-SMase from commercial source was used to raise anti-
serum. Results showed that antiserum recognized the
denatured 28-kDa protein from membrane portion of H. py-
lori. This indicates that the N-SMases produced by both H.
pylori and B. cereus possess common antigenic epitopes,
although we have not yet identi¢ed those regions.
It is now well known that approximately 90% of duodenal
ulcer patients and 60% of gastric ulcer patients are H. pylori
infected, and the patients are at high risk to develop gastric
cancer [2,28,29]. Pathogenic mechanisms behind the e¡ects of
H. pylori on the gastroduodenal mucosa are not fully under-
stood. Enzymes of H. pylori involving gastric diseases such as
urease, catalase, lipase, phospholipase and protease have been
claimed [30]. In ongoing studies searching H. pylori enzymes
involved in pathogenesis, we discovered the presence of
SMase activity in H. pylori. SMase is present in some patho-
genic microorganisms, and it is for the ¢rst time identi¢ed in
H. pylori. Among the bacterial pathogenic factors, investiga-
tions have been insu⁄cient in relation to phospholipases of H.
pylori and pathology. Until detailed studies are performed, it
is not possible to interpret correctly the pathology associated
with H. pylori SMases.
SM hydrolysis through the activation of SMases and gen-
eration of ceramide have been implicated as important signal-
ing pathways in the regulation of cell growth, di¡erentiation,
apoptosis, and in£ammatory responses [31,32]. A number of
extracellular agents such as tumor necrosis factor, interleukin-
1L, nerve growth factor, chemotherapeutic agents, and serum
deprivation, which are known to induce apoptosis, activate
SMase and cause elevation of intracellular ceramide levels
[33^37]. Thus, an interesting question arises whether the bac-
terial membrane-bound SMase from H. pylori acts as an
apoptosis inducer. Further investigation is required to deter-
mine whether H. pylori SMase plays an important role in
apoptosis of gastric cells.
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